Cargando…

Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?

Tissue-resident memory T (T(RM)) cells have emerged as immune sentinels that patrol the tissue microenvironment and orchestrate localized antitumor immunity in various solid cancers. Recent studies have revealed that T(RM) cells are key players in cancer immunosurveillance, and their involvement has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdeljaoued, Syrine, Arfa, Sara, Kroemer, Marie, Ben Khelil, Myriam, Vienot, Angélique, Heyd, Bruno, Loyon, Romain, Doussot, Alexandre, Borg, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039405/ https://www.ncbi.nlm.nih.gov/pubmed/35470231 http://dx.doi.org/10.1136/jitc-2021-003472

Ejemplares similares

Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy
por: Ben Khelil, Myriam, et al.
Publicado: (2022)

Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy
por: Vienot, Angélique, et al.
Publicado: (2022)

CD8(+) CD226(high) T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery
por: Viot, Julien, et al.
Publicado: (2023)

Anti-Telomerase CD4(+) Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
por: Spehner, Laurie, et al.
Publicado: (2020)

Severe COVID-19 patients exhibit an ILC2 NKG2D(+) population in their impaired ILC compartment
por: Gomez-Cadena, Alejandra, et al.
Publicado: (2020)

Epigenetic Reprogramming of CD4(+) Helper T Cells as a Strategy to Improve Anticancer Immunotherapy
por: Renaude, Elodie, et al.
Publicado: (2021)

Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
por: Turinetto, Margherita, et al.
Publicado: (2022)

Novel TGF-β inhibitors ready for prime time in onco-immunology
por: de Gramont, Armand, et al.
Publicado: (2016)

FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
por: Vienot, Angélique, et al.
Publicado: (2020)

SALL4‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features
por: Vienot, Angélique, et al.
Publicado: (2023)

The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment
por: Renaude, Elodie, et al.
Publicado: (2020)

Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
por: Kroemer, Marie, et al.
Publicado: (2020)

Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers
por: Li, Bo, et al.
Publicado: (2023)

We Asked the Experts: How Do We Maintain Surgical Quality Standards for Enhanced Recovery Programs After Cancer Surgery During the COVID-19 Outbreak?
por: Doussot, Alexandre, et al.
Publicado: (2020)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
por: d’Engremont, Christelle, et al.
Publicado: (2021)

REBOA: is it ready for prime time?
por: Doucet, Jay, et al.
Publicado: (2017)

Is pocket ultrasound ready for prime time?
por: Galen, Benjamin T
Publicado: (2012)

Radiotherapy for HCC: Ready for prime time?
por: Bang, Andrew, et al.
Publicado: (2019)

Commentary: Almost ready for prime time
por: Wei, Lawrence M.
Publicado: (2020)

CGM in the Hospital: Is It Ready for Prime Time?
por: Buschur, Elizabeth O., et al.
Publicado: (2022)

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
por: Giannotta, Claudia, et al.
Publicado: (2023)

Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses
por: Loyon, Romain, et al.
Publicado: (2019)

Cholangiocarcinoma: the quest for a second-line systemic treatment
por: Vienot, Angélique, et al.
Publicado: (2019)

Glucocorticoid therapy for trauma - ready for prime time?
por: Aleti, Venkata S, et al.
Publicado: (2012)

CT colonography screening: ready for prime time?
por: Heiken, Jay P.
Publicado: (2009)

Cancer Biomarkers: Are We Ready for the Prime Time?
por: Mishra, Alok, et al.
Publicado: (2010)

Robotic assisted adrenalectomy: Is it ready for prime time?
por: Teo, Xin Ling, et al.
Publicado: (2016)

Are Seizure Detection Devices Ready for Prime Time?
por: Van Ness, Paul C.
Publicado: (2019)

Telemedicine in pediatric otolaryngology: Ready for prime time?
por: Schafer, Austin, et al.
Publicado: (2020)

Zinc–air batteries: are they ready for prime time?
por: Zhang, Jie, et al.
Publicado: (2019)

Commentary: Interesting…maybe not ready for prime time?
por: Chang, Stephanie H.
Publicado: (2021)

Fluorescence optical imaging: ready for prime time?
por: Ohrndorf, Sarah, et al.
Publicado: (2021)

“Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?
por: Ball, Robert, et al.
Publicado: (2022)

Liquid biopsies, are we ready for prime time?
por: Normanno, Nicola, et al.
Publicado: (2023)

Kidney Xenotransplantation: Are We Ready for Prime Time?
por: dos Santos, Rafael Miyashiro Nunes
Publicado: (2023)

Present and Future Research on Anal Squamous Cell Carcinoma
por: Spehner, Laurie, et al.
Publicado: (2021)

PRIME Immunology: Self-directed Introduction to Medical School Immunology
por: Tomasi, Alessandra G., et al.
Publicado: (2021)

Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time
por: Khan, Mahfuzul H., et al.
Publicado: (2009)

Pharmacogenomic Testing and Antithrombotic Therapy: Ready for Prime Time?
por: Holmes, David R.
Publicado: (2013)

Robotic surgery is ready for prime time in India: For the motion
por: Desai, Mahesh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k2fihc5309b58enlo4uh0s1re6